Drug abuse in pregnancy-anesthetic implications

Progress in Anesthesiology

Volumn 15, Issue 20, 2001, Pages 355-369

  Kuczkowski, K M ^a  

^a University of California at San Diego   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CAFFEINE; CANNABIS; OPIATE; SOLVENT; TOLUENE;

ADDICTION; ALCOHOL ABUSE; DRUG ABUSE; DRUG DEPENDENCE; HIGH RISK POPULATION; HUMAN; INTRAVENOUS DRUG ABUSE; OBSTETRIC ANESTHESIA; PREGNANCY; PRENATAL CARE; PRENATAL DRUG EXPOSURE; PREVALENCE; PSYCHOLOGICAL ASPECT; REVIEW; SUBSTANCE ABUSE; TOBACCO;

EID: 0034752269     PISSN: 08915784     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (156)

1. Characteristics of pregnant substance abusers in two cities in the northeast
2. Recognizing illicit drug use in pregnant women: Reports from Oregon birth attendants
3. Maternal and fetal effects of heroin addiction during pregnancy
4. Narcotic use in pregnancy
5. The prevalence of cocaine abuse during pregnancy in Barcelona
6. Cocaine use in pregnancy in Amsterdam
7. Drug and alcohol use in the former Soviet Union: Selected factors and future considerations
8. Cocaine during pregnancy: A critical review of the literature
9. Prevalence of use of cocaine and other substances in an obstetric population
10. Substance abuse patterns in pregnant women
11. The relationship between recent cocaine use and pregnancy outcome
12. Predictors of cocaine use in pregnancy
13. Committee of obstetrics: Maternal and fetal medicine number 114
14. Alcohol consumption by pregnant women in the United States during 1988-1995
15. The definition of alcoholism
16. Les enfants de parents alcooliques: Anomalies observees - A propos de 127 cases
17. Alcohol use in pregnancy
18. Optic nerve hypoplasia in fetal alcohol syndrome: An update
19. Alcohol, astroglia and brain development
20. The diagnosis and treatment of fetal alcohol syndrome
21. Fetal effects of maternal alcohol abuse
22. Effect of the social environment on alcohol involvement and subjective well-being prior to alcoholism treatment
23. Chronic alcohol intake does not change thiopental anesthetic requirement, pharmacokinetics, or pharmaco-dynamics
24. Pharmacology and therapeutic applications of cocaine
25. On the general effects of cocaine (1885)
26. Crack cocaine and cocaine hydrochloride. Are the differences myth or reality?
27. Anatomic actions of cocaine
28. Substance abuse and HIV in pregnancy
29. Cocaine abuse: Neurochemistry, phenomenology and treatment
30. The effects of acute and chronic cocaine use on the heart
31. Pregnancy increases cardiovascular toxicity of cocaine
32. Cardiovascular effects of cocaine during pregnancy
33. Anaesthesia management of a parturient with myocardial infarction related to cocaine use
34. Mechanisms responsible for the cardiotoxic effects of cocaine
35. Cocaine, catecholamines and cardiac toxicity
36. Mechanism of cocaine-induced myocardial depression in dogs
37. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
38. Substance abuse in pregnancy. Symposium on Women's Healthcare
39. Cocaine intoxication presenting as preeclampsia and eclampsia
40. Cocaine screening of parturients without prenatal care: An evaluation of a rapid screening assay
41. Cocaine abusing parturients undergoing cesarean section. A cohort study
42. Cocaine disposition in the meconium from newborns of cocaine-abusing mothers and urine of adult drug users
43. Cocaine use during pregnancy: Sensitive detection by hair assay
44. Cocaine exposure during pregnancy: Improving assessment with radioimmunoassay of maternal hair
45. Maternal, placental and fetal pathophysiology of cocaine exposure during pregnancy
46. Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor
47. Cocaine use during pregnancy: Adverse perinatal outcome
48. Uterine rupture in association with alkaloidal cocaine use
49. Cocaine: How dangerous is it during pregnancy?
50. Uterine rupture associated with recent anteparturn cocaine abuse
51. Cocaine-associated rhabdomyolysis causing renal failure in pregnancy
52. Hepatic rupture in pregnancy associated with cocaine use
53. Transfer of cocaine by the perfused human placenta: The effect of binding to serum proteins
54. Hemodynamic effects of intravenous cocaine on the pregnant ewe and fetus
55. Urogenital anomalies in the offspring of women using cocaine during early pregnancy
56. Cocaine abuse in the parturient: What are the anesthetic implication
57. Drug abuse in the parturient
58. Cocaine, dopamine and the endogenous opioid system
59. Hydralazine does not restore uterine blood flow during cocaine-induced hypertension in the pregnant ewe
60. Cocaine induced hypertension in the ewe and response to treatment with labetalol
61. The management of cocaine-associated myocardial ischemia
62. Cocaine toxicity and the calcium channel blockers nifedipine and nimodipine in rats
63. Cocaine toxicity and isoflurane anesthesia: Hemodynamic, myocardial metabolic, and regional blood flow effects in swine
64. Cardiovascular disease in the pregnant patient. A new risk factor
65. Hypertension and pulmonary oedema associated with ketamine administration in a patient with a history of substance abuse
66. Nitro-glycerine in the treatment of cocaine associated chest pain-clinical safety and efficacy
67. Development of a therapeutic vaccine for the treatment of cocaine addiction
68. Efficacy of a therapeutic cocaine vaccine in rodent models
69. Ecstasy and the dance with death
70. Hazards to health: Dextroamphetamine poisoning
71. Toxicity and deaths from 3,4-methylenedioxymethamphetamine (ecstasy)
72. Amphetamine ingestion presenting as eclampsia
73. Substance abuse in pregnancy. A bigger problem than you think
74. The influence of amphetamine addiction on pregnancy and the newborn infant
75. Amphetamine ingestion with biliary atresia
76. Associations between drugs administered during pregnancy and congenital abnormalities of the fetus
77. The impact of prenatal drug exposure on the neonate
78. Fetal and infant deaths associated with maternal methamphetamine abuse
79. Acute amphetamine abuse: Problems during general anesthesia for neurosurgery
80. Alteration of anesthetic requirement by amphetamine
81. Cardiac arrest in a chronic amphetamine abuser
82. Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission
83. Drug dependence and pregnancy: Antenatal and intrapartum problems
84. Fetal complications of maternal heroin addiction: Abnormal growth, infections and episodes of stress
85. Perinatal and neonatal issues of substance abuse
86. Acute abstinence syndrome after epidural injection of butorphanol
87. Anesthesia and substance abuse
88. Clonidine in acute opiate withdrawal
89. Opiate withdrawal using clonidine: A safe, effective, and rapid monopiate treatment
90. Epidural spinal infection in intravenous drug abusers
91. Parturients infected with human immunodeficiency virus and regional anesthesia: Clinical and immunologic response
92. Early penetration of the blood-brain barrier by HIV
93. The HIV-infected parturient: Is neuraxial anesthesia contraindicated?
94. Adverse effects of cannabis and cannabinoids
95. Health consequences of acute and chronic marihuana use
96. Perinatal and maternal issues of substance abuse
97. Clinical pharmacokinetics of non-opiate abused drugs
98. Biomedical benefits of cannabinoids
99. Effects of maternal marijuana and cocaine use on fetal growth
100. Drug abuse and reproduction
101. The residual cognitive effects of heavy marijuana use in college students
102. The respiratory risks of cannabis smoking
103. A review of recent advances in cannabinoid research and the 1994 international symposium on cannabis and the cannabinoids
104. Adverse effects of cannabis
105. Effects of delta 9-tetrahydrocannabinol on halothane MAC in dogs
106. Preoperative marijuana inhalation - An airway concern
107. Smoking and drinking behavior before and during pregnancy of married mothers of live-born infants and stillborn infants
108. Smoking habits among pregnant women in Norway 1994-1995
109. Substance abuse and HIV in pregnancy
110. Smoking pregnancy and the fetus
111. Oxygen and carbon monoxide equilibria of human adult hemoglobin at atmospheric and elevated pressure
112. Metabolites of a tobacco-specific carcinogen in urine from newborns
113. Substance abuse in pregnancy
114. Cocaine and cigarettes: A comparison of risks
115. Sudden infant death syndrome and smoking in the United States and Sweden
116. The influence of maternal passive and light active smoking on intrauterine growth and body composition of the newborn
117. The effects of cigarette smoking on the human placenta: A light and electron microscopic study
118. Effect of age, parity and smoking on pregnancy outcome: A population based study
119. Effects of smoking during pregnancy
120. Socio-economic status and maternal cigarette smoking before, during and after a pregnancy
121. Recent advances in the pharmacotherapy of smoking
122. Efficacy of bupropion for smoking cessation in nondepressed smokers
123. A controlled trial of sustained release bupropion and nicotine patch or both for smoking cessation
124. Smoking and anesthesia: Preoperative abstinence and perioperative morbidity
125. Low-dose caffeine physical dependence in humans
126. Withdrawal syndrome after the double-blind cessation of caffeine consumption
127. Passage of caffeine into human gonadal and fetal tissue
128. Effects of methylxanthines on the fetus
129. Moderate caffeine use and the risk of spontaneous abortion and intrauterine growth retardation
130. Fetal arrhythmias caused by excessive intake of caffeine by pregnant women
131. Moderate to heavy caffeine consumption during pregnancy and relationship to spontaneous abortion and abnormal fetal growth: A meta-analysis
132. Caffeine-induced disturbance of early neurogenesis in whole mouse embryo cultures
133. Effects of preconceptual caffeine exposure on pregnancy and pregnancy viability
134. Is caffeine withdrawal the mechanism of postoperative headache?
135. Solvent sniffing: Physiological effects and community control measures
136. Changes in autonomic function as determined by ECG P-R interval variability in sandal, shoe and leather workers exposed to n-hexane, xylene and toluene
137. Myocardial infarction and primary ventricular fibrillation after glue sniffing
138. Glue-sniffing and distal renal tubular acidosis: Sticking to the facts
139. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing
140. Toluene sniffing produces cerebellar degeneration
141. Pulmonary function abnormalities in intentional spray paint inhalation
142. Toluene abuse during pregnancy: Obstetric complications and perinatal outcomes
143. Inhalant abuse in pregnancy
144. Toluene embryopathy: Two new cases
145. Toluene Embryopathy
146. Equilibrium disorders with diffuse brain atrophy in long-term toluene sniffing